Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
21 janv. 2021 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...
Impact of COVID-19 on Elective Procedures in the United States - Forecast to 2023: Growth Strategies to Navigate the Uncertainty Surrounding Elective Procedure Deferrals and their Impact
18 janv. 2021 10h13 HE
|
Research and Markets
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Impact of COVID-19 on Elective Procedures in the US, 2020-2023" report has been added to ResearchAndMarkets.com's offering. The study offers an...
Conformis, Inc. to Participate in Upcoming Investor Conferences
31 déc. 2020 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief...
Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System
17 déc. 2020 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. The Company previously...
Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference
24 nov. 2020 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
Conformis Reports Third Quarter 2020 Financial Results
04 nov. 2020 16h10 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Summary Total...
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
28 oct. 2020 18h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
Conformis Reports Preliminary Third Quarter Revenue Results
06 oct. 2020 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected...
Conformis Announces 510(k) Clearance for Cordera™ Hip System
29 sept. 2020 10h45 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip...
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
24 sept. 2020 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to...